Replimune prices upsized public offering of ~$140M; 6.9M shares + pre-funded warrants

Replimune Group, Inc.

Offering includes 6,923,000 common shares at $13.00/share and pre-funded warrants for 3,846,184 shares at $12.9999 each.
Gross proceeds ~$140M; net proceeds estimated at ~$155.8M after full exercise of underwriter option.
Leerink Partners sole bookrunner; closing expected Nov 27, 2024.
Underwriter's 30-day option for 1,615,377 additional shares exercised in full.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.